Open Access<p>Evaluation of the Safety of Bilateral Same-Day Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents: Experience of a Large Korean Retina Center</p>
Author(s) -
Kyuhwan Jang,
Jou-Hyeon Ahn,
Joon Hong Sohn,
Daniel Duck-Jin Hwang
Publication year - 2020
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s276620
Subject(s) - medicine , aflibercept , ranibizumab , endophthalmitis , ophthalmology , macular degeneration , intravitreal administration , bevacizumab , diabetic retinopathy , vascular endothelial growth factor , vitreous hemorrhage , surgery , retinal detachment , retinal , vegf receptors , diabetes mellitus , chemotherapy , endocrinology
To evaluate the short-term ophthalmic side effects of bilateral same-day intravitreal anti-vascular endothelial growth factor (VEGF) injections.